feed,title,long_url,short_url
Benzinga,Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock,https://benzinga.com/analyst-ratings/analyst-color/22/06/27704671/approval-of-baricitinib-for-patchy-baldness-validates-clinical-patch-for-this-small,https://bit.ly/3OeQBRL
